Cutting-edge cancer treatments: expense & expectation? CRUK, 23 February, 2012
Aim of the workshop – For delegates to understand the cost/benefits of new (and existing) technologies and treatments for cancer patients the public expectations of the NHS in providing cancer treatments and the importance of PPI in cancer research and services.
Impact of the workshop –For delegates to apply in their PPI work,an informed patient perspective on the costs/benefits of new (and existing) technologies and treatments for cancer patients in the current economic climate.
Introduction and clarification of aims of the workshop
Richard Stephens, Incoming Chair of CLG & ICPV Member
What do cancer patients want from the NHS? - Laura Thomas, Ipsos MORI
Stratified medicine – What is it and could it reduce costs in long term?
Dr Emily Shaw, Clinical Lead, Stratified Medicine Unit, Cancer Research UK
What is the role of chemoprevention & do we need to licence drugs for this use? What is the future for use of orphan drugs?
Professor Jack Cuzick, Wolfson Institute
Imaging in research and early drug development – role of ECMC What happened to the “Star Wand?”
Prof Kerry Chester UCL , Professor of Molecular Medicine, University College London
Supporting research, protecting patients: Cancer Research UK's recommendations to reform the Clinical Trials Directive (for report on the reform go to our resources page
Emma Greenwood, Policy Manager, CRUK
Delivering World Class Radiotherapy
Tim Cooper, Associate Director-Radiotherapy, National Cancer Action Team
New models of radiotherapy
Dr Jayant Vaidya, Breast Cancer Specialist, University College London
How do we achieve cost effective cancer treatments in the UK?
Prof Peter Littlejohns Kings College London & previously at NICE
Drug pricing issues - Rob Day, Head of Oncololgy, Pfizer
Relationships between the pharma industry and patients - Stuart Pritchard, GSK
Click here for speakers presentations, review of the day and images
Long Term Survivor Study
Continuum Life Sciences are looking for volunteers who have survived aggressive, difficult to treat cancer against all odds to take part in their Long-Term Survivor of Cancer Study. For more information and how you can join go to their website.
Save the planet and donate to ICPV - send ecards go tour Fundraising page for mor information.
VOICE 2020 - Science for Patient Advocates - cancelled
Due to COVID-10 we have had to postpone the course for 2020. Click here for more information.
FAST-Forward Trial Results
A one-week course of radiotherapy in fewer but larger daily doses was found to be as safe and effective as standard three-week therapy for women following surgery for early stage breast cancer. Trial results now published. Two ICPV members provided the PPI for this key trial. Full details can be found on the ICR Website.
ICPV Brighton Summer School Aug 2019
ICPV was once again hosted by SHORE-C at the University of Sussex. Click here for more info.
San Antonio Breast Cancer Symposium, 2018
ICPV member Pat Fairbrother attended this event on an Alamo Foundation Scholarship. Click here to read her review.
Gap Analysis in Breast Surgery Published
The 2013 Breast Cancer Campaign gap analysis established breast cancer research priorities without a specific focus on surgical research or the role of surgeons on breast cancer research. This Review aims to identify opportunities and priorities for research in breast surgery to complement the 2013 gap analysis. Click here for more information
ICPV Review 2018
We have at last published a new edition of our review. This was achieved by a grant from Novartis. Click here for more information.
Award for ICPV Member
Many congratulations to ICPV member Margaret Grayson. On 21 April 2018 she received the Iris Colvin Lifetime Achievement Award for Health, presented by the Women’s Forum of Northern Ireland. This is very well deserved for her tireless work in furthering cancer research especially in Northern Ireland.
At the BACR/ECMC conference in July Maggie Wilcox and Mairead Mackenzie were persuaded to speak to the camera. Maggie gave a background to ICPV and our aims and objectives. While Mairead focused on her specific interests and activities. To view follow the links below.